All Law Enforcement Agencies and Local Government Unit are requested to ensure that this product is not sold or made available in the market or areas of jurisdiction
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Blink Gluta Maxx combines glutathione with lycopene and essential vitamins to enhance its effectiveness and provide additional skin and health benefits
TB-500 (Thymosin Beta-4) Research Wound Healing, Angiogenesis & Keratinocyte Migration (PubMed, 1999) A foundational pre-clinical study published on PubMed investigated Thymosin Beta-4 (TB4) in a rat full-thickness wound model
